OXTRIPHYLLINE PEDIATRIC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oxtriphylline Pediatric, and when can generic versions of Oxtriphylline Pediatric launch?
Oxtriphylline Pediatric is a drug marketed by Morton Grove and is included in one NDA.
The generic ingredient in OXTRIPHYLLINE PEDIATRIC is oxtriphylline. There are three drug master file entries for this compound. Additional details are available on the oxtriphylline profile page.
Summary for OXTRIPHYLLINE PEDIATRIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| Patent Applications: | 2,913 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | OXTRIPHYLLINE PEDIATRIC at DailyMed |
US Patents and Regulatory Information for OXTRIPHYLLINE PEDIATRIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morton Grove | OXTRIPHYLLINE PEDIATRIC | oxtriphylline | SYRUP;ORAL | 088242-001 | Dec 5, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
